Why the study?
The mechanisms underlying the beneficial cardiovascular effects of SGLT2 inhibitors in diabetes are not completely clear, and may involve direct actions on vascular cells.
SGLT2 inhibitors exert direct beneficial effects on endothelial and vascular smooth muscle cells, which likely contributes to their cardioprotective actions beyond glycemic control.
Answers are grounded in this paper and cite their sources.
May contribute to SGLT2 inhibitor cardiovascular benefit in diabetes; leaves open whether effects are SGLT2-specific or off-target.
Cardiovascular disease is the leading cause of morbidity and mortality in diabetes. Recent clinical studies indicate that sodium-glucose co-transporter 2 (SGLT2) inhibitors improve cardiovascular outcomes in patients with diabetes. The mechanism underlying the beneficial effect of SGLT2 inhibitors is not completely clear but may involve direct actions on vascular cells. SGLT2 inhibitors increase the bioavailability of endothelium-derived nitric oxide and thereby restore endothelium-dependent vasodilation in diabetes. In addition, SGLT2 inhibitors favorably regulate the proliferation, migration, differentiation, survival, and senescence of endothelial cells (ECs). Moreover, they exert potent antioxidant and anti-inflammatory effects in ECs. SGLT2 inhibitors also inhibit the contraction of vascular smooth muscle cells and block the proliferation and migration of these cells. Furthermore, studies demonstrate that SGLT2 inhibitors prevent postangioplasty restenosis, maladaptive remodeling of the vasculature in pulmonary arterial hypertension, the formation of abdominal aortic aneurysms, and the acceleration of arterial stiffness in diabetes. However, the role of SGLT2 in mediating the vascular actions of these drugs remains to be established as important off-target effects of SGLT2 inhibitors have been identified. Future studies distinguishing drug- versus class-specific effects may optimize the selection of specific SGLT2 inhibitors in patients with distinct cardiovascular pathologies.
No takes yet. Share an insight, caveat, or question.
Durante et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: